Mr Sven Surikow
School of Medicine
College of Health
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
| Year | Citation |
|---|---|
| 2023 | Horowitz, J. D., & Surikow, S. Y. (2023). Understanding Takotsubo syndrome: first evaluate your mouse model. American Journal of Physiology Heart and Circulatory Physiology, 324(5), H630-H632. |
| 2022 | Laumer, F., Di Vece, D., Cammann, V. L., Würdinger, M., Petkova, V., Schönberger, M., . . . Templin, C. (2022). Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome from Myocardial Infarction. JAMA Cardiology, 7(5), 494-503. Scopus60 WoS57 Europe PMC41 |
| 2022 | Girolamo, O. C., Surikow, S. Y., Ong, G. J., Nguyen, T. H., Kucia, A. M., Chirkov, Y. Y., & Horowitz, J. D. (2022). TakoTsubo Syndrome: First an Acute Coronary Vasculitis and Then Prolonged Myocarditis?. Reviews in Cardiovascular Medicine, 23(5), 152-1-152-9. Scopus4 WoS4 Europe PMC3 |
| 2022 | Ong, G. J., Nguyen, T. H., Surikow, S. Y., & Horowitz, J. D. (2022). Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment options. Expert Review of Clinical Pharmacology, 15(9), 1017-1025. Scopus2 WoS2 Europe PMC1 |
| 2021 | Nguyen, T. H., Surikow, S. Y., & Horowitz, J. D. (2021). Editorial commentary: Takotsubo Syndrome: A key role for inflammation?. Trends in Cardiovascular Medicine, 31(4), 231-232. Scopus3 WoS3 Europe PMC2 |
| 2021 | Ong, G. J., Nguyen, T. H., Kucia, A., Liu, S. -F., Surikow, S. Y., Girolamo, O., . . . Horowitz, J. D. (2021). Takotsubo syndrome: Finally emerging from the shadows?. Heart Lung and Circulation, 30(1), 36-44. Scopus13 WoS13 Europe PMC9 |
| 2020 | Ong, G. J., Nguyen, T. H., Stansborough, J., Surikow, S., Mahadavan, G., Worthley, M., & Horowitz, J. (2020). The N-AcetylCysteine and RAMipril in Takotsubo Syndrome Trial (NACRAM): Rationale and design of a randomised controlled trial of sequential N-Acetylcysteine and ramipril for the management of Takotsubo Syndrome.. Contemporary clinical trials, 90, 105894. Scopus23 WoS22 Europe PMC18 |
| 2020 | Ong, G. J., Nguyen, T. H., Stansborough, J., Surikow, S. Y., & Horowitz, J. D. (2020). Incremental "Therapeutic" Myocardial Exposure to Catecholamines: Incidence and Impact in Takotsubo Syndrome.. Cardiovasc Drugs Ther, 34(1), 95-100. Scopus6 WoS6 Europe PMC5 |
| 2019 | Nguyen, T. H., Stansborough, J., Ong, G. J., Surikow, S., Price, T. J., & Horowitz, J. D. (2019). Antecedent cancer in Takotsubo syndrome predicts both cardiovascular and long-term mortality.. Cardio-Oncology, 5(1), 20-1-20-9. Scopus13 WoS11 Europe PMC5 |
| 2018 | Surikow, S. Y., Nguyen, T. H., Stafford, I., Chapman, M., Chacko, S., Singh, K., . . . Horowitz, J. D. (2018). Nitrosative stress as a modulator of inflammatory change in a model of Takotsubo syndrome. JACC: Basic to Translational Science, 3(2), 213-226. Scopus60 WoS58 Europe PMC41 |
| 2015 | Surikow, S., Raman, B., Licari, J., Singh, K., Nguyen, T., & Horowitz, J. (2015). Evidence of nitrosative stress within hearts of patients dying of Tako-tsubo cardiomyopathy. International Journal of Cardiology, 189(1), 112-114. Scopus28 WoS30 Europe PMC26 |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2023 | Co-Supervisor | Correlation of newer echocardiographic techniques with virtual fractional flow reserve (vFFR)/fractional flow reserve (FFR) in identifying hemodynamically significant coronary artery stenosis in patients with non-ST elevation myocardial infarction. | Master of Clinical Science | Master | Part Time | Miss Pooja Suri |
| 2023 | Co-Supervisor | Correlation of newer echocardiographic techniques with virtual fractional flow reserve (vFFR)/fractional flow reserve (FFR) in identifying hemodynamically significant coronary artery stenosis in patients with non-ST elevation myocardial infarction | - | Master | Part Time | Miss Pooja Suri |
Connect With Me
